Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Ligand Pharmaceuticals Inc. (LGND)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: LGND
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Analysis - Latest Articles
by
most recent
|
most commented
Three Core Biotech Holdings: Isis, Ligand and Vical
Nov 9
•
Michael Steinberg
•
4 Comments
This Week in Biotech: More Treats than Tricks
Nov 1
•
The Burrill Report
•
Comment!
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
Sep 20
•
Justin M. Hall
•
3 Comments
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
Sep 11
•
Justin M. Hall
•
23 Comments
Several Promising Deals for Biotech
Aug 30
•
The Burrill Report
•
1 Comment
Closing Update for Monday, August 24: Markets Essentially Flat
Aug 24
•
Midnight Trader
•
4 Comments
PCAOB: Our Protectors, Encouraging Malfeasance
Jul 15
•
Dividend Inc
•
2 Comments
Stocks Affected by FDA Calendar of Expected Decision Dates
Jan 14
•
Mike Havrilla
•
Comment!
73 Decision Dates on Updated FDA Calendar
Nov 22, 2008
•
Mike Havrilla
•
4 Comments
Backlog of Decisions Is Building at the FDA
Nov 8, 2008
•
Mike Havrilla
•
Comment!
FDA Stings Pharma, Big and Small
Jun 22, 2008
•
Michael Steinberg
•
4 Comments
GSK's Promatica Gets Thumbs Up on NDA
Jun 1, 2008
•
Eben Tessari
•
1 Comment
Loeb's Third Point Issues Latest 13F: Summary of Holdings
Aug 16, 2007
•
Lon Juricic
•
Comment!
Biotech Day In Review: Cell Genesys Climbs On GVAX Results
Apr 4, 2007
•
Centient Biotech Investor
•
Comment!
Ligand Pharmaceuticals: Loeb's ThirdPoint Cuts Stake, Books Profits
Mar 29, 2007
•
Lon Juricic
•
Comment!
Biotech Day in Review: AstraZeneca Buys Arrow Therapeutics
Feb 2, 2007
•
Centient Biotech Investor
•
Comment!
20 Stocks Owned By Top Activist Funds
Dec 21, 2006
•
Mebane Faber
•
Comment!
Curious Retention Agreements at Ligand (LGND)
Mar 14, 2006
•
Footnoted.org
•
1 Comment